DEfining SEPsis on The Wards: point prevalence study

Aneurin Bevan University Health Board0 个研究点目标入组 1,651 人开始时间: 2016年6月17日最近更新: 2023年7月25日

适应症

试验速览

2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29150856 results (added 12/06/2019) 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29637992 results (added 12/06/2019) 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30309393 results (added 12/06/2019) 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30544383 results (added 12/06/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31470569 results (added 13/03/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34376757/ results (added 12/08/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34704060/ (added 10/07/2023) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/35402727/ (added 10/07/2023)

•For the study day (0800 to 0759), consecutive patients presenting to the emergency department (ED) and acute hospital wards with sepsis related admission and patients presenting to the emergency department (ED) and acute hospital wards with acute ongoing sepsis will be enrolled. To be eligible patients must have all of the following:
•1. Must be admitted or transferred to either the ED or hospital ward or critical care area.
•2. Have a NEWS (National Early Warning) score of 3 or above
•3. Have a high clinical suspicion of an infection
•4. Have sepsis as defined by:
•4.1. Either as infection together with two or more SIRS criteria (2012 definition)
•4.2. Or as suspected or documented infection AND a proxy for organ dysfunction (i.e. acute increase of =2 SOFA (Sequential Organ Failure Assessment) points)

发起方